{"success":true,"data":{"pressRelease":{"id":"166715","rtpr_id":"nPn2vKdBVa-20261012","ticker":"STE","exchange":"NYSE","all_tickers":["STE"],"title":"Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)","author":"PR Newswire","published_at":"2026-10-12T18:43:58.694Z","article_body":"Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)\nPR Newswire\n\nPITTSBURGH, Oct. 12, 2026\n\nPITTSBURGH, Oct. 12, 2026 /PRNewswire/ -- Xodus Medical, a leading developer\nand manufacturer of innovative surgical safety solutions, today announced that\nit has entered into an agreement to be acquired by STERIS, a global provider\nof products and services that support patient care with an emphasis on\ninfection prevention.\n\nThe acquisition represents a significant milestone in Xodus Medical's more\nthan 30-year history, bringing together two organizations with a shared\ncommitment to advancing patient safety, supporting healthcare professionals,\nand delivering innovative solutions to the surgical environment. As part of a\nlarger global organization, Xodus Medical looks forward to expanding its\nreach, leveraging complementary capabilities, and delivering even greater\nvalue to its customers.\n\nEqually important is the strong cultural alignment between the two companies.\nBoth organizations share a dedication to product excellence, continuous\nimprovement, and building lasting relationships with the healthcare\nprofessionals they serve. \"Joining STERIS represents an exciting new chapter\nfor Xodus Medical and an opportunity to build upon everything our talented\nteam has accomplished over the past three decades,\" said Craig Kaforey, Chief\nExecutive Officer of Xodus Medical. \"Together, we see tremendous potential to\ndeliver even greater value to our customers by combining our innovative\nproducts and expertise with STERIS's extensive resources, industry knowledge,\nand established market presence. Just as importantly, we believe our shared\nvalues and commitment to excellence will create meaningful opportunities for\nour employees to grow and develop as part of a global organization. I am\nincredibly proud of what our team has accomplished and excited about what lies\nahead.\"\n\nSTERIS is approximately $6 billion in revenue, with 18,000 Associates focused\non providing innovative healthcare and life science products and services\naround the globe. \"Xodus Medical's product portfolio complements and expands\nSTERIS's offering, particularly by adding consumables used in the operating\nroom. Its focus on products that make surgery safer aligns closely with our\nmission to help our Customers create a healthier and safer world,\" said Dan\nCarestio, President and Chief Executive Officer of STERIS. \"The business has\ndemonstrated an ability to grow at double-digit rates with its specialty\nproduct portfolio, a steady stream of new products, and a highly effective\ncommercial team. We look forward to welcoming the Xodus Medical team to\nSTERIS and working together to enhance our service to our customers and value\nfor our shareholders.\"\n\nThroughout its history, Xodus Medical has remained focused on its mission of\nMaking Surgery Safer™. The company believes joining STERIS will further\nstrengthen its ability to support healthcare providers with differentiated\nsolutions that enhance patient safety and improve surgical outcomes.\n\nAdvisors\n\nGoldman Sachs & Co. LLC is serving as exclusive financial advisor to\nSTERIS, and Jones Day is serving as legal counsel. J.P. Morgan is serving as\nexclusive financial advisor to Xodus Medical, and Morgan, Lewis & Bockius\nLLP is serving as legal counsel.\n\nAbout STERIS\n\nSTERIS is a leading global provider of products and services that support\npatient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS\nCREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life\nscience products and services around the globe. For more information, visit\nwww.steris.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4795852-1&h=1545946042&u=http%3A%2F%2Fwww.steris.com%2F&a=www.steris.com)\n.\n\nAbout Xodus Medical\n\nFounded in 1993 and headquartered near Pittsburgh, Pennsylvania, Xodus Medical\nis a leading developer and manufacturer of innovative medical devices\ndedicated to Making Surgery Safer™. The company's comprehensive portfolio of\nproprietary surgical safety technologies, including its flagship Pink Pad®\npatient positioning systems, serves hospitals worldwide. Xodus Medical has\nestablished itself as a trusted partner to healthcare professionals and a\nrecognized leader in perioperative patient safety. For more information, visit\nwww.xodusmedical.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4795852-1&h=3140638326&u=http%3A%2F%2Fwww.xodusmedical.com%2F&a=www.xodusmedical.com)\n.\n\nView original\ncontent:https://www.prnewswire.com/news-releases/xodus-medical-announces-agreement-to-be-acquired-by-steris-nyse-ste-302906035.html\n(https://www.prnewswire.com/news-releases/xodus-medical-announces-agreement-to-be-acquired-by-steris-nyse-ste-302906035.html)\n\nSOURCE Xodus Medical\n\n\n\nBob Johnson, Chief Marketing Officer, Xodus Medical, Inc., bjohnson@xodusmedical.com\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn2vKdBVa-20261012","title":"Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)","author":"PR Newswire","ticker":"STE","created":"2026-10-12T18:43:58.694Z","tickers":["STE"],"exchange":"NYSE","article_body":"Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)\nPR Newswire\n\nPITTSBURGH, Oct. 12, 2026\n\nPITTSBURGH, Oct. 12, 2026 /PRNewswire/ -- Xodus Medical, a leading developer\nand manufacturer of innovative surgical safety solutions, today announced that\nit has entered into an agreement to be acquired by STERIS, a global provider\nof products and services that support patient care with an emphasis on\ninfection prevention.\n\nThe acquisition represents a significant milestone in Xodus Medical's more\nthan 30-year history, bringing together two organizations with a shared\ncommitment to advancing patient safety, supporting healthcare professionals,\nand delivering innovative solutions to the surgical environment. As part of a\nlarger global organization, Xodus Medical looks forward to expanding its\nreach, leveraging complementary capabilities, and delivering even greater\nvalue to its customers.\n\nEqually important is the strong cultural alignment between the two companies.\nBoth organizations share a dedication to product excellence, continuous\nimprovement, and building lasting relationships with the healthcare\nprofessionals they serve. \"Joining STERIS represents an exciting new chapter\nfor Xodus Medical and an opportunity to build upon everything our talented\nteam has accomplished over the past three decades,\" said Craig Kaforey, Chief\nExecutive Officer of Xodus Medical. \"Together, we see tremendous potential to\ndeliver even greater value to our customers by combining our innovative\nproducts and expertise with STERIS's extensive resources, industry knowledge,\nand established market presence. Just as importantly, we believe our shared\nvalues and commitment to excellence will create meaningful opportunities for\nour employees to grow and develop as part of a global organization. I am\nincredibly proud of what our team has accomplished and excited about what lies\nahead.\"\n\nSTERIS is approximately $6 billion in revenue, with 18,000 Associates focused\non providing innovative healthcare and life science products and services\naround the globe. \"Xodus Medical's product portfolio complements and expands\nSTERIS's offering, particularly by adding consumables used in the operating\nroom. Its focus on products that make surgery safer aligns closely with our\nmission to help our Customers create a healthier and safer world,\" said Dan\nCarestio, President and Chief Executive Officer of STERIS. \"The business has\ndemonstrated an ability to grow at double-digit rates with its specialty\nproduct portfolio, a steady stream of new products, and a highly effective\ncommercial team. We look forward to welcoming the Xodus Medical team to\nSTERIS and working together to enhance our service to our customers and value\nfor our shareholders.\"\n\nThroughout its history, Xodus Medical has remained focused on its mission of\nMaking Surgery Safer™. The company believes joining STERIS will further\nstrengthen its ability to support healthcare providers with differentiated\nsolutions that enhance patient safety and improve surgical outcomes.\n\nAdvisors\n\nGoldman Sachs & Co. LLC is serving as exclusive financial advisor to\nSTERIS, and Jones Day is serving as legal counsel. J.P. Morgan is serving as\nexclusive financial advisor to Xodus Medical, and Morgan, Lewis & Bockius\nLLP is serving as legal counsel.\n\nAbout STERIS\n\nSTERIS is a leading global provider of products and services that support\npatient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS\nCREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life\nscience products and services around the globe. For more information, visit\nwww.steris.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4795852-1&h=1545946042&u=http%3A%2F%2Fwww.steris.com%2F&a=www.steris.com)\n.\n\nAbout Xodus Medical\n\nFounded in 1993 and headquartered near Pittsburgh, Pennsylvania, Xodus Medical\nis a leading developer and manufacturer of innovative medical devices\ndedicated to Making Surgery Safer™. The company's comprehensive portfolio of\nproprietary surgical safety technologies, including its flagship Pink Pad®\npatient positioning systems, serves hospitals worldwide. Xodus Medical has\nestablished itself as a trusted partner to healthcare professionals and a\nrecognized leader in perioperative patient safety. For more information, visit\nwww.xodusmedical.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4795852-1&h=3140638326&u=http%3A%2F%2Fwww.xodusmedical.com%2F&a=www.xodusmedical.com)\n.\n\nView original\ncontent:https://www.prnewswire.com/news-releases/xodus-medical-announces-agreement-to-be-acquired-by-steris-nyse-ste-302906035.html\n(https://www.prnewswire.com/news-releases/xodus-medical-announces-agreement-to-be-acquired-by-steris-nyse-ste-302906035.html)\n\nSOURCE Xodus Medical\n\n\n\nBob Johnson, Chief Marketing Officer, Xodus Medical, Inc., bjohnson@xodusmedical.com\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-10-12T18:43:58.740124051Z","server_sent_at_ms":1791830638740},"received_at":"2026-10-12T18:43:58.791Z","source_url":"https://www.prnewswire.com/news-releases/xodus-medical-announces-agreement-to-be-acquired-by-steris-nyse-ste-302906035.html"},"analysis":{"id":"155055","press_release_id":"166715","analysis_json":{"industry":{"label":"Health Care Equipment & Supplies","sector":"Health Care"},"redFlags":["no purchase price or deal terms disclosed"],"eventType":"m_and_a","narrative":"Xodus Medical, a private surgical-safety device maker near Pittsburgh, agreed to be acquired by STERIS (NYSE: STE).\n\nSTERIS management framed the deal as a bolt-on that expands its operating-room consumables portfolio, noting Xodus has grown at double-digit rates with a steady new-product stream.\n\nNo purchase price or terms were disclosed; deal impact for STE shareholders appears incremental rather than transformative. Goldman Sachs and Jones Day advised STERIS; J.P. Morgan and Morgan Lewis advised Xodus.","sentiment":"bullish","agentHooks":{"shouldPost":false,"suggestedAngle":"STERIS tuck-in acquisition adds OR consumables to infection-prevention portfolio — terms undisclosed."},"keyFigures":{"customDimensions":{"steris_associates":18000,"steris_revenue_approx":"$6 billion"}},"quotedText":"Xodus Medical's product portfolio complements and expands STERIS's offering, particularly by adding consumables used in the operating room.","namedEntities":{"people":[{"name":"Craig Kaforey","role":"CEO, Xodus Medical"},{"name":"Dan Carestio","role":"President and CEO, STERIS"},{"name":"Bob Johnson","role":"Chief Marketing Officer, Xodus Medical"}],"products":["Pink Pad patient positioning systems"],"companies":[{"name":"STERIS","ticker":"STE","relationship":"acquirer"},{"name":"Xodus Medical","relationship":"target (private)"},{"name":"Goldman Sachs & Co. LLC","relationship":"financial advisor to STERIS"},{"name":"Jones Day","relationship":"legal counsel to STERIS"},{"name":"J.P. Morgan","relationship":"financial advisor to Xodus Medical"},{"name":"Morgan, Lewis & Bockius LLP","relationship":"legal counsel to Xodus Medical"}],"dollarAmounts":[{"amount":"$6 billion","context":"approximate annual revenue of STERIS"}]},"materialImpact":{"score":2,"reasoning":"STERIS is the acquirer of privately held Xodus Medical, a bolt-on tuck-in adding surgical consumables. No deal value, terms, or financial impact disclosed, so the direct impact on STE is modest."},"tickerRelevance":{"others":[],"primary":"STE"},"globalImportance":25,"audienceRelevance":30,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"large-cap","eventGravity":"tuck-in acquisition, no terms disclosed","targetProfile":"private mid-market target"}},"event_type":"m_and_a","event_type_secondary":null,"sentiment":"bullish","material_impact_score":2,"narrative":"Xodus Medical, a private surgical-safety device maker near Pittsburgh, agreed to be acquired by STERIS (NYSE: STE).\n\nSTERIS management framed the deal as a bolt-on that expands its operating-room consumables portfolio, noting Xodus has grown at double-digit rates with a steady new-product stream.\n\nNo purchase price or terms were disclosed; deal impact for STE shareholders appears incremental rather than transformative. Goldman Sachs and Jones Day advised STERIS; J.P. Morgan and Morgan Lewis advised Xodus.","key_figures":{"customDimensions":{"steris_associates":18000,"steris_revenue_approx":"$6 billion"}},"named_entities":{"people":[{"name":"Craig Kaforey","role":"CEO, Xodus Medical"},{"name":"Dan Carestio","role":"President and CEO, STERIS"},{"name":"Bob Johnson","role":"Chief Marketing Officer, Xodus Medical"}],"products":["Pink Pad patient positioning systems"],"companies":[{"name":"STERIS","ticker":"STE","relationship":"acquirer"},{"name":"Xodus Medical","relationship":"target (private)"},{"name":"Goldman Sachs & Co. LLC","relationship":"financial advisor to STERIS"},{"name":"Jones Day","relationship":"legal counsel to STERIS"},{"name":"J.P. Morgan","relationship":"financial advisor to Xodus Medical"},{"name":"Morgan, Lewis & Bockius LLP","relationship":"legal counsel to Xodus Medical"}],"dollarAmounts":[{"amount":"$6 billion","context":"approximate annual revenue of STERIS"}]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-12T18:44:03.886Z","global_importance":25,"audience_relevance":30,"importance_components":{"tickerTier":"large-cap","eventGravity":"tuck-in acquisition, no terms disclosed","targetProfile":"private mid-market target"}},"durationMs":5083,"modelName":"glm-5.3-flashx"}}